Skip to content
Screener

Kailera Therapeutics KLRA Geographic — Area Of Office Space

Similar metrics at other companies

Moderna logo
MRNACambridge leases — Area of office space (in sqft)
$462K0.0%
MBX Biosciences, Inc. logo
MBXBurlington MA — Area Of Land
$13.64K
Gyre Therapeutics, Inc. logo
GYREBeijing — Square Meter Area For Office Space Under Lease
2.1K0.0%
CubeSmart logo
CUBEMA — Area Of Real Estate Property
$1.25M-0.3%
Nuvation Bio logo
NUVBMA — Area Of Real Estate Property
$2.24K0.0%
Sana Biotechnology logo
SANABothell Washington — Area Of Leased Space
80K0.0%

Other financials

Income statement

See full
Operating income-$84.7M-314%
Net income-$78.9M-339%
EPS (diluted)-$3,650.00+79.7%

Balance sheet

See full
Cash & equivalents$111.8M+9.9%
Total debt$10.5M
Total equity-$432.1M-83.7%
Total assets$624.8M

Cash flow

See full
Operating cash flow-$68.3M-275%

Valuation

See full
Market cap$2.44B-15.8%
Enterprise value$2.34B

Returns & leverage

See full
Debt / equity-0×
Current ratio9.7×

Where this comes from

Reported directly by Kailera Therapeutics in its filing.

Tagged under the XBRL concept ck0002096997:AreaOfOfficeSpace.

The source filing: Kailera Therapeutics’s 10-Q, filed May 26, 2026.

Filed
May 26, 2026, 4:29 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-239417

In March 2025, the Company executed a new, seven-year, non-cancellable operating lease agreement for approximately 39,500 square feet of office space in Waltham, Massachusetts for its corporate headquarters. The lease commenced in October 2025, following completion of construction to prepare the premises for the Company’s intended use. The lease provided for base rent of $2.2 million for the first year, which will increase by approximately 2% each year. The Company’s lease payments also include real estate taxes and other operating expenses allocable to the leased premises, which exceed base year amounts. The Company has the option to extend the lease for one additional five-year term with base rent calculated on the then-market rate. In accordance with the lease agreement, the Company maintained a letter of credit of $0.8 million, which is refundable at the end of the lease term. As of March 31, 2026, the underlying cash balance collateralizing this letter of credit was classified as restricted cash (non-current) on the condensed consolidated balance sheets based on the release date of the restrictions of this cash. In connection with the new lease agreement, the Company amended its previous lease in Waltham, Massachusetts to extend the lease term to end shortly after the lease commencement date of its new lease agreement, which occurred in the fourth quarter of 2025.

Item 1. Financial Statements.

FAQ

What is Kailera Therapeutics's geographic — area of office space?
Kailera Therapeutics (KLRA) reported geographic — area of office space of 39.5K in Q1 2025.
What does geographic — area of office space mean?
This metric measures the total square footage of office and administrative space occupied by the company within the designated geographic segment. It serves as a proxy for the scale of the company's regional administrative and research support operations. Changes in this area over time can indicate shifts in headcount, regional expansion, or consolidation of corporate functions.

Ask your AI about Kailera Therapeutics's geographic — area of office space.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude